Cialis (tadalafil; Lilly) tablets for once daily use have been approved for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (BPH).

CIALIS (tadalafil) tablets Eli Lilly announced that the FDA has approved an addition to the Cialis (tadalafil) label to include data from a 26-week study that showed Cialis 5mg once daily started in ...

Cialis becomes only medication approved in the EU for both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company ...

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has approved Cialis (tadalafil) tablets for once daily use for the treatment of men who have both erectile dysfunction ...

Eli Lilly and Company announced that a pivotal phase III study of Cialis (tadalafil) tablets 5 mg for once daily use met its co-primary endpoints, significantly improving measures of both erectile ...

Pivotal studies support tadalafil for the treatment of benign prostatic hyperplasia and the treatment of both benign prostatic hyperplasia and erectile dysfunction in patients with both conditions.

announced today that the European Commission has approved Cialis 5 mg for once daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cialis was approved for ...

Cialis is turning 10. As Cialis marks its 10 th anniversary this week, Lilly is looking back on the last decade in men's health. "Witnessing the evolution of Cialis since it entered the market 10 ...